- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Poly [ADP-ribose] polymerase 1 (PARP1) is a chromatin-associated nuclear enzyme encoded by the PARP1 gene that regulates DNA repair, transcriptional control, genomic stability, and stress-responsive signaling. PARP1 Antibody / Chromatin Repair Protein Antibody is useful for studying PARylation-associated signaling pathways involved in chromatin remodeling, apoptosis, oxidative stress responses, and nuclear repair biology. PARP1 antibody, also referred to as PARP antibody, Poly ADP-ribose polymerase antibody, ADPRT antibody, or PARylation protein antibody in the literature, recognizes a central DNA repair enzyme that coordinates recruitment of repair machinery to damaged chromatin. This rabbit polyclonal antibody supports investigation of nuclear stress signaling and chromatin-associated repair mechanisms across diverse experimental systems.
PARP1 functions as a rapid sensor of DNA strand breaks and catalyzes transfer of ADP-ribose polymers to target proteins involved in chromatin relaxation and DNA repair complex assembly. Through PARylation-mediated signaling, PARP1 regulates base excision repair, replication stress adaptation, transcriptional activity, inflammatory signaling, and programmed cell death pathways. PARP1 additionally interacts with histones, chromatin remodeling factors, and transcription-associated proteins that influence epigenetic regulation and genomic accessibility. Because PARP1 functions at the interface of chromatin organization and DNA repair signaling, PARP-directed antibodies are widely used in cell biology, cancer research, neurobiology, and therapeutic response studies.
Altered PARP1 signaling has been implicated in cancer progression, neurodegeneration, cardiovascular injury, ischemic stress, inflammatory disease, and metabolic dysfunction. Increased PARP1 activity may contribute to genomic instability and treatment resistance in tumor cells exposed to oxidative injury or replication-associated stress. PARP inhibitors are now widely integrated into targeted oncology strategies involving BRCA-mutated and homologous recombination-deficient tumors. PARP1 additionally participates in stress-induced chromatin remodeling pathways associated with radiation response and chemotherapy adaptation.
At the cellular level, PARP1 demonstrates strong nuclear localization consistent with chromatin-associated DNA repair activity and genomic surveillance functions. Immunohistochemistry and immunofluorescence studies frequently demonstrate diffuse nuclear staining patterns in proliferating cells and tumor tissues. Knockdown validation supports target-specific recognition of PARP1 expression, while broad detection across multiple assay formats supports investigation of chromatin-associated signaling biology. This rabbit polyclonal PARP1 antibody provides a useful approach for studying PARP1-mediated chromatin repair pathways, nuclear stress responses, and DNA damage-associated signaling networks.
Phosphorylation-specific PARP1 reagents targeting DNA damage response activation pathways are available for investigation of phospho-dependent PARP1 signaling and chromatin stress regulation.
Additional PARP1 pathway and chromatin-associated DNA repair studies may benefit from our PARP1 antibody page featuring recombinant rabbit monoclonal clone CFD-16 with knockdown-validated target recognition.
The stated application concentrations are suggested starting points. Titration of the PARP1 Antibody / Chromatin Repair Protein Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Human partial recombinant protein (AA 670-858) was used as the immunogen for this PARP1 antibody.
After reconstitution, the PARP1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
PARP1 antibody, Poly ADP-ribose polymerase antibody, ADPRT antibody, Nuclear repair enzyme antibody, PARylation protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.